Pharmacokinetics of cefamandole in patients with renal failure
- PMID: 848929
- PMCID: PMC351962
- DOI: 10.1128/AAC.11.2.248
Pharmacokinetics of cefamandole in patients with renal failure
Abstract
The pharmacokinetics of cefamandole were studied in four patients with stable renal failure, two patients undergoing peritoneal dialysis, and four patients undergoing hemodialysis. Peak concentrations of cefamandole in serum were achieved 1 to 2 h after intramuscular injection in the patients with stable renal impairment, and the concentrations declined slowly, with half-life values of 12.3 to 18 h. Cefamandole was removed only very slowly by peritoneal dialysis. Hemodialysis was more efficient in removing cefamandole, with serum half-life values ranging from 3.8 to 7.9 h. The mean apparent volume of distribution of cefamandole in these 10 patients was 21.92 liters, or 31% of the body weight.
Similar articles
-
Pharmacokinetics of cefamandole in patients with renal impairment.Antimicrob Agents Chemother. 1979 Feb;15(2):161-4. doi: 10.1128/AAC.15.2.161. Antimicrob Agents Chemother. 1979. PMID: 426510 Free PMC article.
-
Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis.Antimicrob Agents Chemother. 1976 Sep;10(3):457-61. doi: 10.1128/AAC.10.3.457. Antimicrob Agents Chemother. 1976. PMID: 984787 Free PMC article.
-
Pharmacokinetics of cefamandole in the presence of renal failure in patients undergoing hemodialysis.Antimicrob Agents Chemother. 1976 Oct;10(4):623-5. doi: 10.1128/AAC.10.4.623. Antimicrob Agents Chemother. 1976. PMID: 984799 Free PMC article.
-
Pharmacokinetics of cephalosporins in patients with normal or reduced renal function.J Infect Dis. 1978 May;137 Suppl:S88-S99. doi: 10.1093/infdis/137.supplement.s88. J Infect Dis. 1978. PMID: 349098 Review.
-
A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.Ther Drug Monit. 1981;3(2):121-8. doi: 10.1097/00007691-198102000-00002. Ther Drug Monit. 1981. PMID: 6455787 Review.
Cited by
-
Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.Clin Pharmacokinet. 1985 Sep-Oct;10(5):404-25. doi: 10.2165/00003088-198510050-00003. Clin Pharmacokinet. 1985. PMID: 3899455 Review.
-
Pharmacokinetics of cefamandole in patients with renal impairment.Antimicrob Agents Chemother. 1979 Feb;15(2):161-4. doi: 10.1128/AAC.15.2.161. Antimicrob Agents Chemother. 1979. PMID: 426510 Free PMC article.
-
Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.Antimicrob Agents Chemother. 1986 Apr;29(4):649-53. doi: 10.1128/AAC.29.4.649. Antimicrob Agents Chemother. 1986. PMID: 3707113 Free PMC article.
-
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002. Clin Pharmacokinet. 1992. PMID: 1559311 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources